2024
Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series
Rahman S, Kong V, Jalfon M, Hesse D, Kim J, Wright J, Adeniran A, Humphrey P, Martin D, Ghali F. Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series. Cancers 2024, 16: 3050. PMID: 39272908, PMCID: PMC11394101, DOI: 10.3390/cancers16173050.Peer-Reviewed Original ResearchPlasmacytoid urothelial carcinomaMedian overall survivalNeoadjuvant chemotherapyUrothelial carcinomaOverall survivalTreatment patternsReceipt of neoadjuvant chemotherapyResponse to current therapiesCharacterize treatment patternsCox proportional hazards analysisEvaluate treatment patternsSite of metastasisProportional hazards analysisPT0 rateOS benefitHistological subtypesClinical stageCurrent therapiesInstitutional experiencePrimary outcomeNCDBTreatment trendsEffective treatmentPatientsCarcinoma
2021
MP42-17 ASSOCIATION OF TUMOR HISTOLOGY ON IMPACT OF LYMPH NODE DISSECTION ON SURVIVAL IN T2-T3 RENAL CELL CARCINOMA: ANALYSIS OF THE NATIONAL CANCER DATABASE
Ghali F, Cedars B, Patel D, Javier-Desloges J, Meagher M, Yuan J, Hakimi K, Soliman S, Patel S, Ballon-Landa E, Murphy J, Derweesh I. MP42-17 ASSOCIATION OF TUMOR HISTOLOGY ON IMPACT OF LYMPH NODE DISSECTION ON SURVIVAL IN T2-T3 RENAL CELL CARCINOMA: ANALYSIS OF THE NATIONAL CANCER DATABASE. Journal Of Urology 2021, 206: e778-e779. DOI: 10.1097/ju.0000000000002063.17.Peer-Reviewed Original ResearchMP45-12 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT ON INSURANCE STATUS, CANCER STAGE, AND OVERALL SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA
Javier-DesLoges J, Hakimi K, Yuan J, Soliman S, Meagher M, Ghali F, Nawalade V, Patel D, Murphy J, Jolla, CA L, Kim S, Derweesh I. MP45-12 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT ON INSURANCE STATUS, CANCER STAGE, AND OVERALL SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA. Journal Of Urology 2021, 206: e807-e808. DOI: 10.1097/ju.0000000000002066.12.Peer-Reviewed Original ResearchMP66-15 PATIENT-CENTRIC 3 DIMENSIONAL-BIOSYSTEMS FOR DEVELOPING PERSONALIZED IMMUNOTHERAPY FOR PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
Lee S, Muldong M, Hsu J, Ghali F, Kang S, Kader A, Salmasi A, Jamieson C. MP66-15 PATIENT-CENTRIC 3 DIMENSIONAL-BIOSYSTEMS FOR DEVELOPING PERSONALIZED IMMUNOTHERAPY FOR PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA. Journal Of Urology 2021, 206: e1135-e1135. DOI: 10.1097/ju.0000000000002106.15.Peer-Reviewed Original Research
2020
Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database
Patel DN, Ghali F, Meagher MF, Javier-Desloges J, Patel SH, Soliman S, Hakimi K, Yuan J, Murphy J, Derweesh IH. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database. Urologic Oncology Seminars And Original Investigations 2020, 39: 79.e1-79.e8. PMID: 33160847, DOI: 10.1016/j.urolonc.2020.10.015.Peer-Reviewed Original ResearchConceptsUse of RMBRenal mass biopsyRenal cell carcinomaNational Cancer DatabaseCell carcinomaMultivariable analysisCancer DatabaseMass biopsyCharlson Comorbidity IndexCurrent guideline recommendationsYear of diagnosisPopulation-based studySmall renal massesComorbidity indexSurgical treatmentGuideline recommendationsTumor sizeRenal massesPersistent underutilizationPatientsCarcinomaStudy periodTumorsBiopsyHigh rate101 Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study
Dutt R, Meagher M, Patil D, Saito K, Patel D, Ghali F, Keiner C, Miller N, Bradshaw A, Wan F, Yasuda Y, Fujii Y, Master V, Derweesh I. 101 Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study. European Urology Open Science 2020, 19: e236-e237. DOI: 10.1016/s2666-1683(20)32709-9.Peer-Reviewed Original Research161 Safety profile of robotic vs. laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the Robotic Surgery for Upper Tract Urothelial Cancer Study (ROBUUST) collaborative group
Veccia A, Steward J, Derweesh I, Margulis V, Uzzo R, Abdollah F, Minervini A, Cacciamani G, Mottrie A, Simone G, Rha K, Eun D, Mehrazin R, Gonzalgo M, Ghali F, Meng X, Srivastava A, Jamil M, Tellini R, Aron M, Mazzone E, Al-Qathani A, Asghar A, Sundaram C, Autorino R. 161 Safety profile of robotic vs. laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the Robotic Surgery for Upper Tract Urothelial Cancer Study (ROBUUST) collaborative group. European Urology Open Science 2020, 19: e316-e318. DOI: 10.1016/s2666-1683(20)32769-5.Peer-Reviewed Original Research164 Robotic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group
Veccia A, Steward J, Derweesh I, Margulis V, Uzzo R, Abdollah F, Minervini A, Cacciamani G, Mottrie A, Simone G, Rha K, Eun D, Mehrazin R, Gonzalgo M, Ghali F, Meng X, Srivastava A, Jamil M, Riccardo T, Aron M, Mazzone E, Al-Qathani A, Asghar A, Sundaram C, Autorino R. 164 Robotic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group. European Urology Open Science 2020, 19: e322-e324. DOI: 10.1016/s2666-1683(20)32772-5.Peer-Reviewed Original Research836 Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score
Maresma M, Marchioni M, Campi R, Minervini A, Kriegmair M, Heck M, Porpiglia F, Van Bruwaene S, Linares E, Hevia V, Musquera M, Derweesh I, Ghali F, Autorino R, Veccia A, Roussel E, Albertsen M, Pavan N, Antonellia A, Palumbo C, Capitanio U, Klatte T, Erdem S, Rubio-Briones J, Group Y. 836 Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score. European Urology Open Science 2020, 19: e1266-e1267. DOI: 10.1016/s2666-1683(20)33434-0.Peer-Reviewed Original Research846 Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
Meagher M, Mir M, Rubio J, Campi R, Minervini A, Kriegmair M, Heck M, Van Bruwaene S, Linares E, Hevia V, Musquera M, D’anna M, Ghali F, Patel D, Bradshaw A, Autorino R, Guruli G, Rousel E, Albertsen M, Pavan N, Claps F, Antonelli A, Palumbo C, Marchioni M, Derweesh I. 846 Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry. European Urology Open Science 2020, 19: e1285-e1286. DOI: 10.1016/s2666-1683(20)33444-3.Peer-Reviewed Original ResearchPT178 Utility and outcomes of lymph node dissection in T2-3 renal cell carcinoma: Analysis of the national cancer database
Ghali F, Patel D, Meagher M, Patel S, Bradshaw A, Dutt R, Miller N, Keiner C, Eldefrawy A, Murphy J, Derweesh I. PT178 Utility and outcomes of lymph node dissection in T2-3 renal cell carcinoma: Analysis of the national cancer database. European Urology Open Science 2020, 19: e1955-e1956. DOI: 10.1016/s2666-1683(20)33916-1.Peer-Reviewed Original ResearchMP82-16 SFI-UTUC, A NOVEL BASED MORPHOMETRIC SCORING SYSTEM FOR UPPER TRACT UROTHELIAL CELL CARCINOMA: PREDICTING SURVIVAL AND RECURRENCE OUTCOMES
Patel* D, Ghali F, Miller N, Patel S, Meagher M, Dutt R, Hamilton Z, Margulis V, Uzzo R, Derweesh I. MP82-16 SFI-UTUC, A NOVEL BASED MORPHOMETRIC SCORING SYSTEM FOR UPPER TRACT UROTHELIAL CELL CARCINOMA: PREDICTING SURVIVAL AND RECURRENCE OUTCOMES. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000974.016.Peer-Reviewed Original ResearchPD45-02 EVALUATION OF RENAL CELL CARCINOMA INFLAMMATORY SCORE IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA: AN INTERNATIONAL, MULTI-INSTITUTIONAL ANALYSIS
Patil* D, Medline A, Saito K, Lay A, Ghali F, Bilen M, Patel D, Pattaras J, Meagher M, Fukuda S, Yasuda Y, Fujii Y, Ogan K, Derweesh I, Master V. PD45-02 EVALUATION OF RENAL CELL CARCINOMA INFLAMMATORY SCORE IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA: AN INTERNATIONAL, MULTI-INSTITUTIONAL ANALYSIS. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000932.02.Peer-Reviewed Original Research
2019
Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology
Roberts J, Ghali F, Aganovic L, Bechis S, Healy K, Rivera-Sanfeliz G, Autorino R, Derweesh I. Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology. Abdominal Radiology 2019, 44: 3893-3905. PMID: 31701194, DOI: 10.1007/s00261-019-02293-9.Peer-Reviewed Original ResearchConceptsUpper tract urothelial carcinomaUrothelial carcinomaDevelopment of UTUCPost-operative surveillanceRadical extirpative surgeryHigh recurrence rateSpecific clinical situationsMorbid therapyInvasive workupUrothelial malignancyRecurrence rateExtirpative surgeryLethal malignancyNew patientsInvasive proceduresClinical situationsEndoscopic surgeryEnvironmental exposuresDiagnosisPatientsSurgeryCarcinomaMalignancyWorkupClose working relationship